Granulomatous Disease in CVID: Retrospective Analysis of Clinical Characteristics and Treatment Efficacy in a Cohort of 59 Patients

Jean-Nicolas Boursiquot,Laurence Gérard,Marion Malphettes,Claire Fieschi,Lionel Galicier,David Boutboul,Raphael Borie,J.-F. Viallard,Pauline Soulas-Sprauel,Alice Bérezné,Arnaud Jaccard,Eric Hachulla,Julien Haroche,N. Schleinitz,L. Têtu,Eric Oksenhendler

Granulomatous Disease in CVID: Retrospective Analysis of Clinical Characteristics and Treatment Efficacy in a Cohort of 59 Patients

2013

Jean-Nicolas Boursiquot
Laurence Gérard
Marion Malphettes
Claire Fieschi
Lionel Galicier
David Boutboul
Raphael Borie
J.-F. Viallard
Pauline Soulas-Sprauel
Alice Bérezné
Arnaud Jaccard
Eric Hachulla
Julien Haroche
N. Schleinitz
L. Têtu
Eric Oksenhendler

Background Granulomatous disease (GD) will develop in a subset of patients with common variable immunodeficiency (CVID). Little is known about the efficacy of therapeutic agents used for treating this disorder.

Keywords:

Prospective cohort study
Immunophenotyping
Organ Specificity
Cohort
Common variable immunodeficiency
Disease
Immunology
Retrospective cohort study
Cohort study
Medicine
antibody deficiency
treatment efficacy
Medical microbiology
granulomatous disease
retrospective analysis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations